OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Virology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Structure of SARS-CoV-2 spike protein	120
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	111
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection	98
Recent advances in antiviral drug development towards dengue virus	71
Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles	70
Future considerations for the mRNA-lipid nanoparticle vaccine platform	60
Zoonotic disease and virome diversity in bats	58
Current challenges to virus discovery by meta-transcriptomics	57
Global overview and major challenges of host prediction methods for uncultivated phages	53
Structure and function of SARS-CoV-2 polymerase	51
Coronavirus entry: how we arrived at SARS-CoV-2	50
Animal models for SARS-CoV-2	49
Dengue vaccine development by the year 2020: challenges and prospects	49
A new generation of vaccines based on alphavirus self-amplifying RNA	44
The virome of vector mosquitoes	44
The healthy human virome: from virus–host symbiosis to disease	43
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	42
A structural view of the SARS-CoV-2 virus and its assembly	42
An update on salicylic acid biosynthesis, its induction and potential exploitation by plant viruses	42
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus	41
COVID-19, the first pandemic in the post-genomic era	39
Engineering therapeutic phages for enhanced antibacterial efficacy	39
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses	39
A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination	39
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi	38

Structure, function and assembly of the long, flexible tail of siphophages	34
Viral Z-RNA triggers ZBP1-dependent cell death	34
European regulatory aspects of phage therapy: magistral phage preparations	34
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	33
Host cell-intrinsic innate immune recognition of SARS-CoV-2	33
Anti-viral protective capacity of tissue resident memory T cells	32
Dengue mouse models for evaluating pathogenesis and countermeasures	32
Salicylic acid: transport and long-distance immune signaling	32
Risk factors and biomarkers of severe dengue	31
Perspective on taxonomic classification of uncultivated viruses	31
Tombusviruses orchestrate the host endomembrane system to create elaborate membranous replication organelles	31
Measles virus persistence and its consequences	30
Detection of viruses by inflammasomes	29
Influenza D virus	29
Entry of influenza A virus into host cells — recent progress and remaining challenges	28
Structure, dynamics and phase separation of measles virus RNA replication machinery	28
Mitigation of evolved bacterial resistance to phage therapy	27
Viral structural proteins as targets for antivirals	27
Current view and perspectives in viroid replication	26
Rotavirus cell entry: not so simple after all	26
Natural killer cells and unconventional T cells in COVID-19	26
Adenovirus – a blueprint for gene delivery	26
Extracellular vesicles in virus infection and pathogenesis	25
Progress and pitfalls of a year of drug repurposing screens against COVID-19	25
Drug resistance mutations in HIV: new bioinformatics approaches and challenges	25
Critical view on RNA silencing-mediated virus resistance using exogenously applied RNA	23
Measles virus in cancer therapy	23
Animal morbilliviruses and their cross-species transmission potential	23
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach	22
Immune system control of hepatitis C virus infection	22
Mapping the diverse structural landscape of the flavivirus antibody repertoire	22
Proteases and variants: context matters for SARS-CoV-2 entry assays	22
Animal models of SARS-CoV-2 transmission	22
Hepatitis B virus–host interactions and novel targets for viral cure	22
Molecular dynamics of the viral life cycle: progress and prospects	21
Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone	21
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	21
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world	21
Rapid diagnostic tests to address challenges for global measles surveillance	21
Tissues: the unexplored frontier of antibody mediated immunity	21
Nucleic acid-mediated PAMP-triggered immunity in plants	21
R gene mediated defense against viruses	20
Measles Resurgence and Drug Development	20
Epigenetic control of the Epstein-Barr lifecycle	20
Cytomegalovirus as an immunomodulator across the lifespan	20
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005	19
Revisiting an old friend: new findings in alphavirus structure and assembly	19
Targeting of viral RNAs by Upf1-mediated RNA decay pathways	19
Measles pathogenesis, immune suppression and animal models	19
Development of plant-made monoclonal antibodies against viral infections	19

Phage therapy for secondary bacterial infections with COVID-19	19
The long and winding road: human papillomavirus entry and subcellular trafficking	18
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses	18
An overview of the current state of phage therapy for the treatment of biofilm-related infections	18
Measles immunity and immunosuppression	18
Evolution of the interferon response: lessons from ISGs of diverse mammals	18
The gut virome in inflammatory bowel diseases	18